Quantcast

Health Care Sector Update for 07/27/2017: CUR,CAPR,IPCI


Shutterstock photo

Top Health Care Stocks

JNJ -0.61%

PFE +0.05%

ABT -0.71%

MRK +3.43%

AMGN -2.77%

Health care stocks were leading the U.S. markets lower this afternoon, with with the NYSE Health Care Index falling nearly 1.0% while shares of health care companies in the S&P 500 were down more than 0.9% as a group.

In company news, Neuralstem ( CUR ) fell to a record low on Thursday, dropping 30% to a worst-ever $1.73 a share after the biopharmaceuticals company priced a $6 million public offering of 3 million shares at $2 apiece, a 19% discount to Wednesday's closing price.

The offering also included warrants to buy up to 2.3 million additional shares anytime over the next seven years, also exercisable at $2 each.

In other sector news,

(+) CAPR, (+25.0%) Duchenne Muscular dystrophy designated by the U.S. Food and Drug Administration as a rare pediatric disease, making the company's CAP-1002 drug candidate eligible for a priority review voucher after receiving FDA marketing approval.

(-) IPCI, (-47.2%) FDA advisory panel votes 22-to-1 against approving the company's extended release oxycodone tablets, saying there was a lack of data about the drug's abuse-deterrence properties.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.





This article appears in: Investing , US Markets
Referenced Symbols: CUR , CAPR ,




More from MT Newswires

Subscribe






MT Newswires
Contributor:

MT Newswires

Market News, Commodities












Research Brokers before you trade

Want to trade FX?